Original source (on modern site) | Article images: [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19]
Chinese Company Under Congressional Scrutiny Makes Key U.S. Drugs Lawmakers raising national security concerns and seeking to disconnect a major Chinese firm from U.S. pharmaceutical interests have rattled the biotech industry. The firm is deeply involved in development and manufacturing of crucial therapies for cancer, cystic fibrosis, H.I.V. and other illnesses. By Christina Jewett Global Health Old and Young, Talking Again A society in which members of different generations do not interact "is a dangerous experiment," said one researcher. By Paula Span When a Spouse Goes to the Nursing Home The move to a long-term care facility is often difficult but necessary for frail patients. For their partners, it can mean a new set of challenges. By Paula Span Facing Financial Ruin as Costs Soar for Elder Care The United States has no coherent system for providing long-term care, leading many who are aging to struggle to stay independent or to rely on a patchwork of solutions. By Reed Abelson and Jordan Rau Extra Fees Drive Assisted-Living Profits The add-ons pile up: $93 for medications, $50 for cable TV. Prices soar as the industry leaves no service unbilled. The housing option is out of reach for many families. By Jordan Rau Why Long-Term Care Insurance Falls Short for So Many The private insurance market has proved wildly inadequate in providing financial security for millions of older Americans, in part by underestimating how many policyholders would use their coverage. By Jordan Rau and JoNel Aleccia Take This Dance Class and Call Me in the Morning Prescriptions for social activities, exercise and the arts — first popularized in Britain — are coming to America. But some experts say the U.S. health care system may get in the way. By Christina Caron The New Old Age
More in The New Old Age ›Dying Broke
More in Dying Broke ›From Well
More in From Well ›